icient design of anticancer treatments for patients with metastatic melanoma to the brain MRA Young Investigator Award, 2017-2020 Manuel Valiente, Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III "Smart" nanoparticles for immunotherapeutic targeting of the STING pathway: Plans to engineer an innovative, innate immunity-targeting